W. Uyterlinde

发表

Cetuximab in combination with single agent daily cisplatin chemotherapy concurrent with radiotherapy in locally advanced nonsmall cell lung carcinoma: A feasibility study

M. Verheij, J. Belderbos, N. Zandwijk, 2011 .

Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab.

J. Aerts, E. Dieleman, M. Verheij, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment adherence in concurrent chemoradiation in patients with locally advanced non-small cell lung carcinoma: results of daily intravenous prehydration.

J. Sonke, J. Belderbos, M. M. van den Heuvel, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prognostic parameters for acute esophagus toxicity in intensity modulated radiotherapy and concurrent chemotherapy for locally advanced non-small cell lung cancer.

J. Sonke, J. Belderbos, M. M. van den Heuvel, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin.

P. Baas, J. Belderbos, E. van Werkhoven, 2013, Clinical lung cancer.

Non-small cell lung cancer, locally advanced

P. Lambin, S. Kozlov, I. Petersen, 2012 .

Immunotherapy Bridge 2019 and Melanoma Bridge 2019: meeting abstracts

Infante, K. Sikorska, M. Sznol, 2020, Journal of Translational Medicine.

Immuun- en targeted therapie

J. Haanen, W. Uyterlinde, H. Mallo, 2021, Leerboek oncologieverpleegkunde.

Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients

P. Baas, A. H. Maitland‐van der Zee, R. Masereeuw, 2020, Frontiers in Pharmacology.

Switch to checkpoint inhibition (CPI) after targeted therapy (TT) at time of progression or during ongoing response: A retrospective analysis of patients with advanced BRAF mutated melanoma.

E. Rozeman, C. Blank, J. Haanen, 2018, Annals of Oncology.

Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter?

J. Bussink, D. de Ruysscher, G. Bootsma, 2016, Lung cancer.

89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer.

I. C. Kok, H. Groen, G. Hospers, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Overcoming toxicity-challenges in chemoradiation for non-small cell lung cancer.

W. Uyterlinde, 2016, Translational lung cancer research.

A randomized, multicenter phase II study investigating additional weekly cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: Reporting on the efficacy.

J. Aerts, E. Dieleman, M. Verheij, 2012 .

Relating Acute Esophageal Toxicity to Radiation Therapy Dose Using 18FDG-PET in Concurrent Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer

J. Sonke, J. Belderbos, M. Rossi, 2012 .

Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer.

Jan-Jakob Sonke, Jasper Nijkamp, Jose Belderbos, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

OC-0498 CONCURRENT CHEMORADIOTHERAPY WITH OR WITHOUT CETUXIMAB IN NSCLC; TOXICITY RESULTS OF A RANDOMIZED PHASE II TRIAL

J. Aerts, E. Dieleman, M. Verheij, 2012 .

Solitary Bone Metastasis Appearing outside the Usual Range of FDG PET/CT in Stage III Lung Cancer: Is Total Body FDG PET/CT ImagingMandatory?

W. Uyterlinde, J. Fanggiday, M. V. D. Heuvel, 2012 .

Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy.

J. Sonke, J. Belderbos, M. M. van den Heuvel, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Supportive Care in Lung Cancer: Milestones Over the Past 40 Years

A. Molassiotis, M. Krishnasamy, L. Sarna, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating.

J. Aerts, E. Dieleman, M. Verheij, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients

Joseph O. Deasy, Jose Belderbos, Philippe Lambin, 2015, International journal of radiation oncology, biology, physics.

Fractures of thoracic vertebrae in patients with locally advanced non-small cell lung carcinoma treated with intensity modulated radiotherapy.

J. Sonke, J. Belderbos, M. M. van den Heuvel, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

152 Clinical prediction for acute toxicity in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiation

P. Baas, J. Belderbos, M. Kwint, 2012 .

Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.

Jan-Jakob Sonke, Marcel van Herk, Jasper Nijkamp, 2012, International journal of radiation oncology, biology, physics.

Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.

M. V. van Herk, J. Sonke, J. Belderbos, 2012, International journal of radiation oncology, biology, physics.